Filter posts

Green Light for CAR-T Leukemia Treatment Is an Historic Moment for Biotechnology

I’ve been President and CEO of BIO for more than a dozen years, and I’ve been …

Curing Cancer: Advancements and What is Yet to Come

  Last month, MIT Technology Review reported “Two Infants Treated with Universal Immune Cells Have …

T-Cell Therapies: Best Bets in Pushing Down the Cost Curve and Prioritizing Cancer Targets

New approaches in cancer immunology are achieving promising early-stage results through novel techniques for arming …